- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0001958

Progresive Lifesciences Private Limited
About Progresive Lifesciences Private Limited
Data last updated:
Progresive Lifesciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2005PTC438097. Its GSTIN is 05AAECP0409P1ZD (Uttarakhand).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹31.2 Lakh. It is led by directors Rajesh Kumar Hariharprasad Tiwari and Menpal Singh.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No 14 Block – H Pkt 5, Sector 16 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.81 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Cr (net margin 3.5%) and EBITDA of ₹2.47 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 26% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹5.01 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Progresive Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0001958). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Progresive Lifesciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230DL2005PTC438097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230DL2005PTC438097 | Current |
| U24230BR2005PTC011361 | Previous |
| U24231BR2005PTC011361 | Previous |
Recognitions & Rankings of Progresive Lifesciences
Contact details
Progresive Lifesciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No 14 Block – H Pkt 5, Sector 16 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Progresive Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Progresive Lifesciences Private Limited
FY 2024 filings availableProgresive Lifesciences Private Limited reported revenue of ₹37.81 Cr (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 28% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹37.81 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Progresive Lifesciences Private Limited, buy the company report.
Board of directors of Progresive Lifesciences Private Limited
Progresive Lifesciences has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Hariharprasad Tiwari Also directs: Antex Pharma Private Limited, Alexza Labs Private Limited | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
| Menpal Singh | Director | 15 Jul 2022 | 4 Years 4 Months | Current |
Auditor
Progresive Lifesciences Private Limited is audited by ANKIT JAIN for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT JAIN | FY 2024 | 548019 |
Shareholding
The shareholding of Progresive Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Progresive Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2022 | 100542011 | Axis Bank Limited | ₹2 Cr | Open | |
| 21 Jan 2013 | 10399363 | Hdfc Bank Limited | ₹2.11 Cr | Satisfied | |
| 29 Nov 2007 | 10079390 | Bank of India Muradpur Chauhatta Branch | ₹2.9 Cr | Satisfied |
To see the full charge records of Progresive Lifesciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Progresive Lifesciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed against the company | Disposed |
To see the full case history of Progresive Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Progresive Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Progresive Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECP0409P1ZD | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Progresive Lifesciences Private Limited, buy the company report.
Recent activity
Progresive Lifesciences Private Limited has 14 board changes on record since 2007: 2 appointments and 12 cessations. The latest: Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 27 Sep 2024.
13 earlier events are in the company report.
Frequently asked questions
Progresive Lifesciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 May 2005 (21+ years old) and is registered under CIN U24230DL2005PTC438097.
Progresive Lifesciences has 2 current directors:
- Rajesh Kumar Hariharprasad Tiwari - Director
- Menpal Singh - Director
The latest financial statements of Progresive Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Progresive Lifesciences is 05AAECP0409P1ZD, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Progresive Lifesciences is U24230DL2005PTC438097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Progresive Lifesciences has 1 court case on record: 1 filed against it.
Progresive Lifesciences was incorporated on 20 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Rajesh Kumar Hariharprasad Tiwari was appointed as Director on 27 Sep 2024. Amardeep Bansal ceased to be Managing Director on 18 May 2023. Menpal Singh was appointed as Director on 15 Jul 2022. Progresive Lifesciences has 14 board changes on record in total.
Yes, Progresive Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0001958).
The registered office of Progresive Lifesciences is at House No 14 Block – H Pkt 5, Sector 16 Rohini, Delhi, India – 110085.

